From Lab to Launch Podcast: Testing a Gene Therapy to Potentially Cure HIV & Fundamentally Change Healthcare with Jeff Galvin

CEO Jeff Galvin was interviewed on the From Lab to Launch podcast

From Lab to Launch by Qualio

Jeff is the CEO and founder of American Gene Technologies®. He earned his BA degree in Economics from Harvard and has more than 30 years of business and entrepreneurial experience including founder or executive positions at various Silicon Valley startups. Following his startup experience, he retired to become an Angel Investor in real estate and high tech. He came out of retirement to found and fund AGT after meeting Roscoe Brady at NIH and the incredible projects he was working on in gene and cell therapy. Jeff has contagious energy for gene technology and the future of curing for the incurable like HIV, cancer, and PKU.

Subscribe to Press Release and News Updates

Subscribe to our press release and published article updates to be notified when we release new content!